We are live on ! Find out more

643 hedge funds and large institutions have $12.7B invested in Sanofi in 2022 Q4 according to their latest regulatory filings, with 121 funds opening new positions, 203 increasing their positions, 206 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

120% more first-time investments, than exits

New positions opened: 121 | Existing positions closed: 55

119% more call options, than puts

Call options by funds: $145M | Put options by funds: $66.5M

33% more capital invested

Capital invested by funds: $9.61B → $12.7B (+$3.13B)

21% more funds holding in top 10

Funds holding in top 10: 1417 (+3)

10% more funds holding

Funds holding: 587643 (+56)

0.58% more ownership

Funds ownership: 20.12%20.69% (+0.58%)

1% less repeat investments, than reductions

Existing positions increased: 203 | Existing positions reduced: 206

Holders
643
Holders Change
+56
Holders Change %
+9.54%
% of All Funds
10.34%
Holding in Top 10
17
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+21.43%
% of All Funds
0.27%
New
121
Increased
203
Reduced
206
Closed
55
Calls
$145M
Puts
$66.5M
Net Calls
+$79M
Net Calls Change
-$79.8M
Name Holding Trade Value Shares
Change
Change in
Stake
Dodge & Cox
1
Dodge & Cox
California
$4.08B +$375M +8,538,408 +11%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$963M +$74.2M +1,690,624 +9%
Boston Partners
3
Boston Partners
Massachusetts
$884M +$23M +523,705 +3%
Fisher Asset Management
4
Fisher Asset Management
Washington
$667M -$8.99M -204,875 -1%
BlackRock
5
BlackRock
New York
$475M -$26.9M -613,381 -6%
Bank of America
6
Bank of America
North Carolina
$440M -$81M -1,844,367 -17%
Morgan Stanley
7
Morgan Stanley
New York
$375M +$54.9M +1,251,199 +19%
CCM
8
Camber Capital Management
Massachusetts
$339M -$21.9M -500,000 -7%
Invesco
9
Invesco
Georgia
$297M +$24.4M +556,328 +10%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$272M +$108M +2,456,030 +78%
Millennium Management
11
Millennium Management
New York
$176M +$76.2M +1,735,396 +91%
JP Morgan Chase
12
JP Morgan Chase
New York
$168M -$1.83M -41,647 -1%
Arrowstreet Capital
13
Arrowstreet Capital
Massachusetts
$166M -$25.2M -573,617 -14%
T. Rowe Price Associates
14
T. Rowe Price Associates
Maryland
$139M -$413M -9,420,070 -77%
Adage Capital Partners
15
Adage Capital Partners
Massachusetts
$126M +$82.7M +1,883,825 +264%
Goldman Sachs
16
Goldman Sachs
New York
$122M +$3.18M +72,537 +3%
Hotchkis & Wiley Capital Management
17
Hotchkis & Wiley Capital Management
California
$119M -$5.41M -123,150 -5%
N
18
Nuveen
North Carolina
$100M +$90.9M +2,071,780 New
MSE
19
MUFG Securities EMEA
United Kingdom
$96.3M +$43.9M +1,000,000 New
SI
20
Sofinnova Investments
California
$95.2M +$30.8M +700,929 +55%
EIC
21
Equity Investment Corp
Georgia
$93.3M +$16.4M +373,685 +24%
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$83.2M -$2.8M -63,742 -4%
Natixis Advisors
23
Natixis Advisors
Massachusetts
$81.7M +$35.7M +813,365 +93%
Wells Fargo
24
Wells Fargo
California
$79.6M -$3.25M -73,979 -4%
American Century Companies
25
American Century Companies
Missouri
$78.8M +$21.4M +488,516 +43%

SNY Hedge Fund Activity: Q4 2022 in Review

643 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q4 2022, worth a combined $12.7B — up 33% from $9.61B a quarter earlier.

Buyers outnumbered sellers: 121 funds opened new SNY positions and 55 closed out — a net gain of 66 holders — while 203 added to existing stakes and 206 trimmed.

The largest buyer was Dodge & Cox, adding an estimated $375M. The largest seller was T. Rowe Price Associates, cutting an estimated $413M.

  • 643 institutional investors held Sanofi (SNY) as of Q4 2022, up from 587 in Q3 2022.
  • Funds reported $12.7B of Sanofi stock for Q4 2022, up 33% quarter-over-quarter.
  • 121 funds opened new Sanofi positions in Q4 2022 and 55 closed out, a net change of +66 holders.
  • The largest Sanofi buyer in Q4 2022 was Dodge & Cox, an estimated $375M added.
  • The largest Sanofi seller in Q4 2022 was T. Rowe Price Associates, an estimated $413M sold.

Based on aggregated 13F filings for Q4 2022.